Skip to content
ASM Microbe 2018 #644 “In Vivo Efficacy of Non-Hydroxamate LpxC Inhibitors in Murine Infection Models”Zak2018-06-12T15:47:13-07:00
ASM Microbe 2018 #643 “Antimicrobial Activity of Non-Hydroxamate LpxC Inhibitors”Zak2018-06-12T15:48:53-07:00
ASM Microbe 2018 LB19 “Improved Gram-negative Antibacterial Activity Upon Combination of LpxC Inhibitor FG-944 and RNA Polymerase Inhibitors (Rifampin or APY281)Zak2018-06-12T15:43:14-07:00
ECCMID – Forging New Therapies for Multidrug Resistant InfectionsZak2018-04-11T14:33:57-07:00
2017 Keystone Symposia Conference “Antimicrobials and Resistance: Opportunities and Challenges”Zak2017-10-31T01:13:12-07:00
2017 ASM ESCMID – In Vivo Characterization of Non-hydroxamate LpxC Inhibitorsaceli2017-09-28T17:10:16-07:00
2017 ASM ESCMID – In Vitro Characterization of Non-hydroxamate LpxC Inhibitorsaceli2017-10-06T18:29:22-07:00
2017 ASM MICROBE – In Vitro and In Vivo Characterization of Non-hydroxamate LpxC Inhibitorsaceli2017-10-06T18:31:01-07:00
Page load link
ASM Microbe 2018 LB19 “Improved Gram-negative Antibacterial Activity Upon Combination of LpxC Inhibitor FG-944 and RNA Polymerase Inhibitors (Rifampin or APY281) Gallery
